Hong Kong Stocks Movement | MEDBOT-B (02252) Rises Over 7% in Early Trading After Completing World's First Large Model Autonomous Surgery Animal Experiment

Stock News01-12

MEDBOT-B (02252) surged more than 7% in early trading. As of writing, the stock was up 5.7%, trading at HK$26.7 with a turnover of HK$115 million. The company recently announced the successful completion of the world's first in-vivo animal experiment for "large model autonomous surgery," powered by its self-developed "MicroGenius" multi-modal autonomous surgical large model. This achievement is unprecedented in existing public literature and medical practice, marking the first time globally that a multi-modal autonomous surgical large model has driven a surgical robot to complete critical procedural steps autonomously in a live animal scenario. Notably, the company previously announced that, based on internal preliminary statistics, the cumulative orders for its core products in laparoscopy, orthopedics, and vascular intervention have exceeded 230 units. Among them, the core product Toumai laparoscopic surgical robot (Toumai) has accumulated over 160 commercialized orders globally, including nearly 120 new orders secured this year. According to public statistics, Toumai's global order volume for 2025 has already ranked second worldwide.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1131436346?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-12 10:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1131436346","market":"hk","top_or_hot":-1,"title":"Hong Kong Stocks Movement | MEDBOT-B (02252) Rises Over 7% in Early Trading After Completing World's First Large Model Autonomous Surgery Animal Experiment","media":"Stock News","content":"<p>MEDBOT-B (02252) surged more than 7% in early trading. As of writing, the stock was up 5.7%, trading at HK$26.7 with a turnover of HK$115 million.\nThe company recently announced the successful completion of the world's first in-vivo animal experiment for \"large model autonomous surgery,\" powered by its self-developed \"MicroGenius\" multi-modal autonomous surgical large model.\nThis achievement is unprecedented in existing public literature and medical practice, marking the first time globally that a multi-modal autonomous surgical large model has driven a surgical robot to complete critical procedural steps autonomously in a live animal scenario.\nNotably, the company previously announced that, based on internal preliminary statistics, the cumulative orders for its core products in laparoscopy, orthopedics, and vascular intervention have exceeded 230 units.\nAmong them, the core product Toumai laparoscopic surgical robot (Toumai) has accumulated over 160 commercialized orders globally, including nearly 120 new orders secured this year.\nAccording to public statistics, Toumai's global order volume for 2025 has already ranked second worldwide.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong Stocks Movement | MEDBOT-B (02252) Rises Over 7% in Early Trading After Completing World's First Large Model Autonomous Surgery Animal Experiment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong Stocks Movement | MEDBOT-B (02252) Rises Over 7% in Early Trading After Completing World's First Large Model Autonomous Surgery Animal Experiment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-01-12 10:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>MEDBOT-B (02252) surged more than 7% in early trading. As of writing, the stock was up 5.7%, trading at HK$26.7 with a turnover of HK$115 million.\nThe company recently announced the successful completion of the world's first in-vivo animal experiment for \"large model autonomous surgery,\" powered by its self-developed \"MicroGenius\" multi-modal autonomous surgical large model.\nThis achievement is unprecedented in existing public literature and medical practice, marking the first time globally that a multi-modal autonomous surgical large model has driven a surgical robot to complete critical procedural steps autonomously in a live animal scenario.\nNotably, the company previously announced that, based on internal preliminary statistics, the cumulative orders for its core products in laparoscopy, orthopedics, and vascular intervention have exceeded 230 units.\nAmong them, the core product Toumai laparoscopic surgical robot (Toumai) has accumulated over 160 commercialized orders globally, including nearly 120 new orders secured this year.\nAccording to public statistics, Toumai's global order volume for 2025 has already ranked second worldwide.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1617","symbol_name":"AI医疗","start_time":0,"source_url":"","article_id":"1131436346","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1131436346","pubTimestamp":1768184904,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"MEDBOT-B (02252) surged more than 7% in early trading. As of writing, the stock was up 5.7%, trading at HK$26.7 with a turnover of HK$115 million. The company recently announced the successful...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1617":"AI医疗","BK1100":"医疗保健设备","02252":"微创机器人-B"},"translate_title":"港股动向|MEDBOT-B(02252)完成全球首个大模型自主手术动物实验早盘涨超7%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02252":1},"content_text":"MEDBOT-B (02252) surged more than 7% in early trading. As of writing, the stock was up 5.7%, trading at HK$26.7 with a turnover of HK$115 million.\nThe company recently announced the successful completion of the world's first in-vivo animal experiment for \"large model autonomous surgery,\" powered by its self-developed \"MicroGenius\" multi-modal autonomous surgical large model.\nThis achievement is unprecedented in existing public literature and medical practice, marking the first time globally that a multi-modal autonomous surgical large model has driven a surgical robot to complete critical procedural steps autonomously in a live animal scenario.\nNotably, the company previously announced that, based on internal preliminary statistics, the cumulative orders for its core products in laparoscopy, orthopedics, and vascular intervention have exceeded 230 units.\nAmong them, the core product Toumai laparoscopic surgical robot (Toumai) has accumulated over 160 commercialized orders globally, including nearly 120 new orders secured this year.\nAccording to public statistics, Toumai's global order volume for 2025 has already ranked second worldwide.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1131436346","isCrawlerRequest":true}